GRNA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
GRNA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GreenLight Biosciences Holdings PBC's basic earnings per share (Basic EPS) for the three months ended in Mar. 2023 was $-0.19. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2023 was $-1.13.
GreenLight Biosciences Holdings PBC's EPS (Diluted) for the three months ended in Mar. 2023 was $-0.19. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 was $-1.13.
GreenLight Biosciences Holdings PBC's EPS without NRI for the three months ended in Mar. 2023 was $-0.19. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2023 was -1.13.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
The historical data trend for GreenLight Biosciences Holdings PBC's EPS (Basic) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GreenLight Biosciences Holdings PBC Annual Data | |||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | |||||
EPS (Basic) | -0.39 | -0.69 | -0.91 | -1.27 |
GreenLight Biosciences Holdings PBC Quarterly Data | ||||||||||||
Dec19 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | |
EPS (Basic) | Get a 7-Day Free Trial | -0.34 | -0.42 | -0.27 | -0.25 | -0.19 |
EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.
GreenLight Biosciences Holdings PBC's Basic EPS for the fiscal year that ended in Dec. 2022 is calculated as
Basic EPS (A: Dec. 2022 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Basic Average) |
= | (-167.055 | - | 0) | / | 131.976 | |
= | -1.27 |
GreenLight Biosciences Holdings PBC's Basic EPS for the quarter that ended in Mar. 2023 is calculated as
Basic EPS (Q: Mar. 2023 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Basic Average) |
= | (-28.469 | - | 0) | / | 151.614 | |
= | -0.19 |
EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.13
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GreenLight Biosciences Holdings PBC (NAS:GRNA) EPS (Basic) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Thank you for viewing the detailed overview of GreenLight Biosciences Holdings PBC's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.
Deval L Patrick | other: See Remarks | BAIN CAPITAL, LLC, 200 CLARENDON STREET, BOSTON MA 02116 |
Dennis A. Clarke | other: Member of 13D group owning 10% | 6 FERNWAY TERRACE, WINCHESTER MA 01890 |
Cummings Foundation, Inc. | other: Member of 13D group owning 10% | 200 WEST CUMMINGS PARK, WOBURN MA 01801 |
Eric Senior Anderson | other: Member of 13D group owning 10% | 25 N HILL ROAD, WESTOVER MA 01886 |
Mls Capital Fund Ii Lp | other: See remarks | C/O MLSC II (GP) (LABUAN) LLP, ONE MARKET ST SUITE 3525, SAN FRANCISCO CA 94105 |
Chelt Trading Ltd | other: Member of 13D Group | C/O FOX HORAN & CAMERINI LLP, 885 3RD AVENUE, 17TH FLOOR, NEW YORK NY 10022 |
Highview Trust | other: Member of 13D Group | C/O FOX HORAN & CAMERINI LLP, 885 THIRD AVENUE, 17TH FLOOR, NEW YORK NY 10022 |
Montealegre Lacayo Jaime Javier | other: Member of 13D Group | APARTADO 15-1250, ESCAZU G2 |
Furneaux Capital Holdco, Llc | other: Member of 13D group | 1 MARINA PARK DRIVE, BOSTON MA 02210 |
Lewis & Clark Plant Sciences Fund I, Lp | other: Member of 13D group | 120 S. CENTRAL AVENUE, SUITE 1000, ST. LOUIS MO 63105 |
Lewis & Clark Ventures I, Lp | other: Member of 13D group | 120 S. CENTRAL AVENUE, SUITE 1000, ST. LOUIS MO 63105 |
Matthew Allen Walker | director, 10 percent owner | C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC, 200 BOSTON AVENUE, SUITE 3100, MEDFORD MA 02155 |
Martha Schlicher | director | C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC, 200 BOSTON AVENUE, SUITE 3100, MEDFORD MA 02155 |
Marta Ortega-valle | other: Member of 10% owner group | C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC, 200 BOSTON AVENUE, SUITE 3100, MEDFORD MA 02155 |
Builders Vision, Llc | 10 percent owner | 110 NW 2ND STREET SUITE 300, BENTONVILLE AR 72712 |
From GuruFocus
By Business Wire Business Wire • 05-30-2023
By GuruFocusNews GuruFocusNews • 03-14-2022
By GuruFocusNews GuruFocusNews • 06-09-2022
By PRNewswire PRNewswire • 06-15-2023
By PurpleRose PurpleRose • 08-01-2022
By sperokesalga sperokesalga • 05-11-2023
By GuruFocusNews GuruFocusNews • 05-20-2022
By GuruFocusNews GuruFocusNews • 05-30-2022
By Marketwired • 07-24-2023
By sperokesalga sperokesalga • 03-30-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.